News
- Author:
- Amy Karon
Publish date: January 7, 2019
Only 15.2% of patients had multiple sclerosis or amyotrophic lateral sclerosis, the diagnoses of patients in the studies leading to the approval of...
News
- Author:
- Amy Karon
Publish date: January 7, 2019
In a phase 2 trial of 15 adults with progressive HER2-mutant NSCLC, objective response rate was 53%, median overall survival was 12.9 months, and m...
News
- Author:
- Amy Karon
Publish date: January 3, 2019
The risk of death was three- to fivefold higher than that in the general population.
News
- Author:
- Amy Karon
Publish date: January 3, 2019
Metachronous advanced neoplasia was diagnosed in similar proportions of patients with and without high-risk diminutive polyps.
News
- Author:
- Amy Karon
Publish date: January 2, 2019
Rates of colectomy were similar whether patients received induction immunotherapy with infliximab at weeks 0, 2, and 6, or on an accelerated schedu...
News
- Author:
- Amy Karon
Publish date: January 2, 2019
Rates of clinical remission were 16.1% and 1.3%, respectively (P less than .001).
News
- Author:
- Amy Karon
Publish date: December 21, 2018
Two recent studies highlight the ability of vedolizumab and tofacitinib to rapidly improve symptoms reported by patients with inflamma...
News
- Author:
- Amy Karon
Publish date: November 28, 2018
Compared with esophagectomy, ESD was associated with significantly fewer severe adverse perioperative events and a similar rate of all-cause mortal...
News
- Author:
- Amy Karon
Publish date: November 27, 2018
Both biologics induced clinically meaningful improvements in patient-reported outcomes early in the course of treatment.
News
- Author:
- Amy Karon
Publish date: November 26, 2018
Significant predictors included baseline nonalcoholic fatty liver disease activity score greater than 5, baseline triglycerides up to 154 mg/dL, an...
News
- Author:
- Amy Karon
Publish date: November 26, 2018
Staying up to date on screening was associated with a 62% decrease in the odds of dying from colorectal cancer.
News
- Author:
- Amy Karon
Publish date: November 1, 2018
Fully 79% of patients achieved clinical remission with budesonide.
News
- Author:
- Amy Karon
Publish date: November 1, 2018
An HBV DNA load less than 20 IU/mL in patients with decompensated cirrhosis significantly improved the chances of long-term survival.
News
- Author:
- Amy Karon
Publish date: November 1, 2018
The mortality benefit appeared to be limited to patients with ascites fluid protein levels under 15 g/L.
News
- Author:
- Amy Karon
Publish date: November 1, 2018
High-risk HPV DNA was detected in anal tissue specimens from 30% of patients with Crohn’s disease versus 18% of patients without Crohn’s disease.
